Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merck in talks to buy cancer biotech Seagen for about $40 billion By: MarketWatch July 06, 2022 at 22:42 PM EDT Merck & Co. is in advanced talks to acquire Seagen Inc. and is aiming to finalize a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that could be worth roughly $40 billion or more. Read More >> Related Stocks: Merck & Co Seagen Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Merck in talks to buy cancer biotech Seagen for about $40 billion By: MarketWatch July 06, 2022 at 22:42 PM EDT Merck & Co. is in advanced talks to acquire Seagen Inc. and is aiming to finalize a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that could be worth roughly $40 billion or more. Read More >> Related Stocks: Merck & Co Seagen Inc